May 4, 2020

Drug Eluting Stent Market By Polymer Type, By End-User, By Material Type,By Geography – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2019 – 2026

The global drug eluting stent market size is expected to witness a high growth during the forecast period, 2019 - 2026. Major growth factors such as medical advancements across the global market and high demand for minimally invasive techniques for arterial disease is likely to trigger the market growth.

Get Sample Report: DrugEluting Stent Market

Drug eluting stents (DES) come in two forms for clinical use, i.e. taxus stent and cypher stent. At present, a limited range of devices are available with respect to the dimensions. However, they are recommended for wound and abrasions. The clinical effect of DES can be assessed in terms of major cardiac events and lessening of revascularization of the wound. As per the studies, the efficiency of drug eluting stents is higher as compared with conventional stents depending on the type of design and intended purpose.  Clinical studies and meta-analysis for DES also reveals that DES minimizes the risk of revascularization upto 80%.

Commercially, the drug eluting stent market is highly receptive towards techno-medical advancements and significant pricing. However, public-private partnerships and other innovations led by market entrants are likely to catalyse the market growth throughout the forecast period. Also, effective segregation of patients based on the type of disease and health patterns proves instrumental in selecting a DES approach.

Drug Eluting Stent Market Trends, Drivers and Opportunities:

The market growth is significantly driven by worldwide rise in geriatric population that are vulnerable to develop arterial diseases arising out of lifestyle disorders such as excessive smoking, high consumption of alcohol and unhealthy foods and insomnia. In addition, medical professionals prefer minimally invasive techniques to resolve arterial cases which in turn propels the market growth for drug eluting stents. A major trend observed across the global market is adoption of modernized approach in healthcare. Increasing awareness levels in patients is another trend witnessed. However, cost of treatment and availability of alternative therapies limits the approach towards DES ultimately constricting the market growth.